{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:43:58Z","timestamp":1777869838371,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S100D021548"],"award-info":[{"award-number":["S100D021548"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016223","name":"University of Rochester Wilmot Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016223","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijrobp.2022.10.033","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T01:39:34Z","timestamp":1668562774000},"page":"972-982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevention of Radiation-Induced Bladder Injury: A Murine Study Using Captopril"],"prefix":"10.1016","volume":"115","author":[{"given":"Angela M.","family":"Groves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Paris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hernady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Aljitawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Kerns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Marples","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.10.033_bib0001","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-J","article-title":"The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy","volume":"31","author":"Marks","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/COC.0000000000000016","article-title":"Hemorrhagic radiation cystitis","volume":"38","author":"Mendenhall","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0003","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.ijrobp.2009.02.090","article-title":"Radiation dose-volume effects of the urinary bladder","volume":"76","author":"Viswanathan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0004","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bju.14516","article-title":"Current management of radiation cystitis: A review and practical guide to clinical management","volume":"123","author":"Pascoe","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0005","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(19)30494-2","article-title":"Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): A randomised, controlled, phase 2-3 trial","volume":"20","author":"Oscarsson","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0006","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrurol.2010.23","article-title":"Management of radiation cystitis","volume":"7","author":"Smit","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0007","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jnci\/djz075","article-title":"Radiogenomics consortium genome-wide association study meta-analysis of late toxicity after prostate cancer radiotherapy","volume":"112","author":"Kerns","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pros.20486","article-title":"Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer","volume":"67","author":"Kosaka","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0009","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/01.CIR.95.6.1532","article-title":"Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis","volume":"95","author":"Hernandez-Presa","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0010","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.RES.87.12.1195","article-title":"Role of NAD(P)H oxidase in angiotensin II-induced JAK\/STAT signaling and cytokine induction","volume":"87","author":"Schieffer","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111254","article-title":"Renin-angiotensin system and inflammation update","volume":"529","author":"Cantero-Navarro","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0012","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2022.01.014","article-title":"Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer","volume":"168","author":"Kerns","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0013","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1667\/RR13425.1","article-title":"Model development and use of ace inhibitors for preclinical mitigation of radiation-induced injury to multiple organs","volume":"182","author":"Medhora","year":"2014","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0014","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0360-3016(93)90425-U","article-title":"Treatment of radiation nephropathy with ace inhibitors","volume":"27","author":"Moulder","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0015","doi-asserted-by":"crossref","first-page":"F1422","DOI":"10.1152\/ajprenal.00350.2018","article-title":"Void spot assay: Recommendations on the use of a simple micturition assay for mice","volume":"315","author":"Hill","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0016","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.juro.2015.03.108","article-title":"Intravesical liposomal tacrolimus protects against radiation cystitis induced by 3-beam targeted bladder radiation","volume":"194","author":"Rajaganapathy","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0017","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0018","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: A comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0019","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0020","doi-asserted-by":"crossref","first-page":"23335","DOI":"10.18632\/oncotarget.8024","article-title":"Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer","volume":"7","author":"Silvers","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0021","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.juro.2014.02.035","article-title":"Bladder cancer exosomes contain EDIL-3\/Del1 and facilitate cancer progression","volume":"192","author":"Beckham","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0022","doi-asserted-by":"crossref","first-page":"91199","DOI":"10.18632\/oncotarget.20043","article-title":"Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer","volume":"8","author":"Silvers","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0023","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1074\/jbc.RA118.006682","article-title":"Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells","volume":"294","author":"Wu","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0024","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s13287-021-02600-6","article-title":"Non-stem bladder cancer cell-derived extracellular vesicles promote cancer stem cell survival in response to chemotherapy","volume":"12","author":"Chung","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0025","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41416-021-01554-z","article-title":"Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer","volume":"125","author":"Silvers","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111401","article-title":"An indispensable tool: Exosomes play a role in therapy for radiation damage","volume":"137","author":"Li","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0027","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41401-021-00615-6","article-title":"Exosomes are involved in total body irradiation-induced intestinal injury in mice","volume":"42","author":"Li","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2019.12.003","article-title":"An emerging interplay between extracellular vesicles and cytokines","volume":"51","author":"Aiello","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0029","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.3390\/ijms21197096","article-title":"The role and impact of extracellular vesicles in the modulation and delivery of cytokines during autoimmunity","volume":"21","author":"Hussain","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0030","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/cells10071596","article-title":"Extracellular vesicles in organ fibrosis: Mechanisms, therapies, and diagnostics","volume":"10","author":"Brigstock","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0031","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1182\/blood-2004-02-0744","article-title":"Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells","volume":"104","author":"Beleslin-Cokic","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0032","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2125.1992.tb05644.x","article-title":"Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers","volume":"34","author":"Pratt","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0033","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2018.12.003","article-title":"Pelvic complications after prostate cancer radiation therapy and their management: An international collaborative narrative review","volume":"75","author":"Matta","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0034","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0039","article-title":"Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: The NRG Oncology RTOG 0126 randomized clinical trial","volume":"4","author":"Michalski","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0035","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0036","first-page":"743","article-title":"Nomograms to predict late urinary toxicity after prostate cancer radiotherapy","volume":"32","author":"Mathieu","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0037","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijrobp.2016.05.017","article-title":"Macroscopic hematuria after conventional or hypofractionated radiation therapy: Results from a prospective phase 3 study","volume":"96","author":"Sanguineti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0038","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.adro.2016.07.004","article-title":"Modeling of chronic radiation-induced cystitis in mice","volume":"1","author":"Zwaans","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0039","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2307\/3579834","article-title":"Radiation-induced impairment of urinary bladder function in mice: Fine structure of the acute response and consequences on late effects","volume":"151","author":"Dorr","year":"1999","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0040","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2007.05.074","article-title":"Effect of recombinant human keratinocyte growth factor (rHuKGF, Palifermin) on radiation-induced mouse urinary bladder dysfunction","volume":"69","author":"Jaal","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0041","doi-asserted-by":"crossref","first-page":"19277","DOI":"10.1038\/s41598-021-98303-2","article-title":"Voiding defects in acute radiation cystitis driven by urothelial barrier defect through loss of E-cadherin, ZO-1 and Uroplakin III","volume":"11","author":"Zwaans","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0042","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.juro.2006.07.138","article-title":"Radiation induced late damage to the barrier function of small blood vessels in mouse bladder","volume":"176","author":"Jaal","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0043","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: Exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0044","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/0929866523666160427105138","article-title":"The influence of ionizing radiation on exosome composition, secretion and intercellular communication","volume":"23","author":"Jelonek","year":"2016","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103365","article-title":"Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy","volume":"67","author":"Zhou","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0046","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/cancers11020136","article-title":"Role of extracellular vesicles (EVs) in cell stress response and resistance to cancer therapy","volume":"11","author":"O'Neill","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0047","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.3390\/ijms20153649","article-title":"Ionizing radiation increases the activity of exosomal secretory pathway in MCF-7 human breast cancer cells: A possible way to communicate resistance against radiotherapy","volume":"20","author":"Jabbari","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0048","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5347(17)45087-7","article-title":"Successful management of radiation cystitis with sodium pentosanpolysulfate","volume":"136","author":"Parsons","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0049","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: The effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: New roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0051","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2174\/138161207780618821","article-title":"Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists","volume":"13","author":"Moulder","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijrobp.2022.10.033_bib0052","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/095530098142257","article-title":"Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy","volume":"73","author":"Moulder","year":"1998","journal-title":"Int J Radiat Biol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622035155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622035155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:49:19Z","timestamp":1777560559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622035155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0360301622035155"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.10.033","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of Radiation-Induced Bladder Injury: A Murine Study Using Captopril","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}